SPARSENTAN for Focal segmental glomerulosclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 57 adverse event reports in the FDA FAERS database where SPARSENTAN was used for Focal segmental glomerulosclerosis.
Most Reported Side Effects for SPARSENTAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dizziness | 521 | 15.9% | 0 | 27 |
| Fatigue | 448 | 13.7% | 0 | 29 |
| Hypotension | 377 | 11.5% | 3 | 28 |
| Product use in unapproved indication | 262 | 8.0% | 4 | 8 |
| Nausea | 231 | 7.0% | 1 | 13 |
| Peripheral swelling | 197 | 6.0% | 0 | 16 |
| Headache | 186 | 5.7% | 0 | 9 |
| Pruritus | 171 | 5.2% | 0 | 7 |
| Blood creatinine increased | 145 | 4.4% | 0 | 19 |
| Glomerular filtration rate decreased | 141 | 4.3% | 0 | 14 |
| Off label use | 123 | 3.8% | 1 | 6 |
| Blood pressure decreased | 122 | 3.7% | 1 | 7 |
| Blood potassium increased | 109 | 3.3% | 0 | 14 |
| Wrong technique in product usage process | 108 | 3.3% | 0 | 3 |
| Vomiting | 104 | 3.2% | 0 | 6 |
Other Indications for SPARSENTAN
Iga nephropathy (2,583)
Product used for unknown indication (356)
Haematuria (334)
Chronic kidney disease (293)
Proteinuria (197)
Nephritic syndrome (52)
Nephrotic syndrome (42)
Illness (12)
Nephropathy (11)
Acute kidney injury (7)
Other Drugs Used for Focal segmental glomerulosclerosis
RITUXIMAB (309)
CORTICOTROPIN (298)
TACROLIMUS (216)
CYCLOSPORINE (199)
PREDNISONE (189)
MYCOPHENOLATE MOFETIL (177)
PREDNISOLONE (108)
METHYLPREDNISOLONE (89)
CYCLOPHOSPHAMIDE (49)
OBINUTUZUMAB (20)